Yektaş, ÇiğdemTufan, Ali Evren2020-04-302020-04-3020170362-56641537-162Xhttps://doi.org/10.1097/WNF.0000000000000205https://hdl.handle.net/20.500.12684/3347Tufan, ALI EVREN/0000-0001-5207-6240; Yektas, Cigdem/0000-0002-5951-7253WOS: 000397829400006PubMed: 28118168Trichotillomania (TTM) is a mental disorder characterized by uncontrolled and impulsive hair pulling leading to hair loss, distress, and disordered functioning. Treatment choices include behavioral therapy (especially habit reversal training) and selective serotonin reuptake inhibitors. However, randomized controlled trials conducted with selective serotonin reuptake inhibitors have led to controversial results of effectiveness for TTM. Here, we report a female patient whose TTM symptoms increased after fluoxetine use.en10.1097/WNF.0000000000000205info:eu-repo/semantics/closedAccessfluoxetinetrichotillomaniachildhoodReview Article4029596WOS:000397829400006Q3Q4